Literature DB >> 576768

Human testosterone-oestradiol binding globulin in health and disease.

R V Wenn, I A Kamberi, P Vossough, M H Kariminejad, E Torabee, M Keyvanjah, N Sarberi.   

Abstract

Levels of testosterone-oestradiol binding globulin (TeBG) were measured by a precipitation technique in terms of dihydrotestosterone-5alpha (DHT) binding capacity in children, adult males and females, pregnant and hirsute women and women with various trophoblastic disorders. It was found that TeBG levels in children of either sex (1.92 +/- 0.16 mug DHT bound/100 ml serum) approached the normal female range (2.31 +/- 0.11) and were distinctly higher than those of the adult male (1.04 +/- 0.09). In both pregnancy and trophoblastic disease (hydatidiform mole and choriocarcinoma but not metastatic choriocarcinoma) TeBG levels were elevated (17.5 +/- 0.70 and 14.9 +/- 1.49, respectively). In hirsutism TeBG was depressed (1.17 +/- 0.09) and comparable with the levels in normal male subjects. A number of other parameters, HCG, oestradiol-17 beta, testosterone and progesterone were measured and found to be similar to those previously reported in the literature. It appears that TeBG titre might provide an additional index in following the prognosis of trophoblastic disorders, besides HCG measurement.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576768     DOI: 10.1530/acta.0.0840850

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  2 in total

1.  Detection of genetic variation with radioactive ligands. V. Genetic variants of testosterone-binding globulin in human serum.

Authors:  A Luckock; L L Cavalli-Sforza
Journal:  Am J Hum Genet       Date:  1983-01       Impact factor: 11.025

2.  Androblastoma: pre-, per- and post-operative steroid hormone and binding protein concentrations in peripheral plasma, cyst fluid and tumor vein.

Authors:  P H Rolland; P M Martin; A M Rolland; F Laffargue; H Serment
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.